
<div id="jpedal" style="overflow: hidden; position: relative; width: 893px; height: 1196px;">
<style type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position:absolute;
	white-space:nowrap;
	overflow:visible;
}
</style>
<style type="text/css" >

#t1_2{left:68px;top:105px;letter-spacing:-0.1px;word-spacing:15.6px;}
#t2_2{left:68px;top:124px;word-spacing:14.7px;}
#t3_2{left:68px;top:142px;word-spacing:5.1px;}
#t4_2{left:234px;top:141px;}
#t5_2{left:86px;top:160px;word-spacing:4.7px;}
#t6_2{left:68px;top:179px;word-spacing:0.3px;}
#t7_2{left:68px;top:197px;word-spacing:4.9px;}
#t8_2{left:68px;top:215px;word-spacing:4.9px;}
#t9_2{left:68px;top:234px;word-spacing:11.9px;}
#ta_2{left:68px;top:252px;word-spacing:26px;}
#tb_2{left:68px;top:270px;word-spacing:0.9px;}
#tc_2{left:68px;top:289px;}
#td_2{left:109px;top:288px;}
#te_2{left:143px;top:289px;word-spacing:7.2px;}
#tf_2{left:68px;top:307px;word-spacing:3.5px;}
#tg_2{left:68px;top:325px;word-spacing:2.7px;}
#th_2{left:68px;top:344px;word-spacing:0.7px;}
#ti_2{left:68px;top:362px;word-spacing:7.4px;}
#tj_2{left:68px;top:380px;word-spacing:13.5px;}
#tk_2{left:68px;top:399px;word-spacing:5.1px;}
#tl_2{left:127px;top:398px;letter-spacing:1.2px;}
#tm_2{left:86px;top:417px;word-spacing:1.6px;}
#tn_2{left:68px;top:435px;word-spacing:16.6px;}
#to_2{left:68px;top:454px;word-spacing:11.9px;}
#tp_2{left:68px;top:472px;word-spacing:11.9px;}
#tq_2{left:68px;top:490px;word-spacing:5.2px;}
#tr_2{left:366px;top:489px;}
#ts_2{left:403px;top:490px;}
#tt_2{left:68px;top:509px;word-spacing:7.1px;}
#tu_2{left:68px;top:527px;word-spacing:24.9px;}
#tv_2{left:68px;top:545px;word-spacing:0.2px;}
#tw_2{left:68px;top:564px;word-spacing:3.1px;}
#tx_2{left:68px;top:582px;word-spacing:5.1px;}
#ty_2{left:86px;top:600px;letter-spacing:-0.8px;word-spacing:0.8px;}
#tz_2{left:68px;top:619px;letter-spacing:-1px;}
#t10_2{left:68px;top:637px;letter-spacing:-1px;word-spacing:0.5px;}
#t11_2{left:68px;top:655px;letter-spacing:-1px;word-spacing:6.4px;}
#t12_2{left:68px;top:674px;letter-spacing:-1px;word-spacing:4.8px;}
#t13_2{left:68px;top:692px;letter-spacing:-1px;word-spacing:3.9px;}
#t14_2{left:68px;top:710px;letter-spacing:-1px;word-spacing:11.9px;}
#t15_2{left:68px;top:729px;letter-spacing:-1px;word-spacing:11.4px;}
#t16_2{left:68px;top:747px;letter-spacing:-1.2px;}
#t17_2{left:103px;top:746px;letter-spacing:-0.8px;}
#t18_2{left:135px;top:747px;letter-spacing:-0.9px;word-spacing:2.8px;}
#t19_2{left:68px;top:765px;letter-spacing:-1px;word-spacing:3.1px;}
#t1a_2{left:68px;top:784px;letter-spacing:-0.9px;word-spacing:1.5px;}
#t1b_2{left:68px;top:802px;letter-spacing:-1px;word-spacing:3.6px;}
#t1c_2{left:68px;top:858px;word-spacing:16.7px;}
#t1d_2{left:68px;top:887px;word-spacing:5.1px;}
#t1e_2{left:68px;top:905px;word-spacing:5.1px;}
#t1f_2{left:68px;top:922px;word-spacing:0.6px;}
#t1g_2{left:68px;top:939px;word-spacing:13.9px;}
#t1h_2{left:68px;top:956px;word-spacing:-0.4px;}
#t1i_2{left:68px;top:972px;letter-spacing:-0.7px;word-spacing:4.5px;}
#t1j_2{left:68px;top:989px;letter-spacing:-0.9px;word-spacing:2.5px;}
#t1k_2{left:68px;top:1006px;letter-spacing:-1.1px;word-spacing:4.2px;}
#t1l_2{left:68px;top:1023px;letter-spacing:-1.8px;word-spacing:1.9px;}
#t1m_2{left:68px;top:1048px;}
#t1n_2{left:68px;top:1066px;word-spacing:3.7px;}
#t1o_2{left:68px;top:1083px;word-spacing:6.4px;}
#t1p_2{left:68px;top:1100px;word-spacing:4.1px;}
#t1q_2{left:68px;top:1117px;word-spacing:12.8px;}
#t1r_2{left:68px;top:1134px;word-spacing:14.7px;}
#t1s_2{left:471px;top:105px;word-spacing:0.2px;}
#t1t_2{left:471px;top:122px;word-spacing:14.3px;}
#t1u_2{left:471px;top:139px;word-spacing:6.3px;}
#t1v_2{left:471px;top:156px;}
#t1w_2{left:490px;top:173px;word-spacing:3.5px;}
#t1x_2{left:471px;top:189px;word-spacing:9.1px;}
#t1y_2{left:471px;top:206px;word-spacing:1px;}
#t1z_2{left:471px;top:223px;word-spacing:-1.6px;}
#t20_2{left:471px;top:240px;word-spacing:-1.4px;}
#t21_2{left:471px;top:257px;word-spacing:-0.7px;}
#t22_2{left:471px;top:273px;word-spacing:7px;}
#t23_2{left:471px;top:290px;word-spacing:3.7px;}
#t24_2{left:471px;top:307px;word-spacing:4.6px;}
#t25_2{left:490px;top:324px;word-spacing:5.3px;}
#t26_2{left:471px;top:341px;word-spacing:14.5px;}
#t27_2{left:471px;top:357px;word-spacing:5.8px;}
#t28_2{left:471px;top:374px;word-spacing:6.8px;}
#t29_2{left:471px;top:391px;word-spacing:1.4px;}
#t2a_2{left:471px;top:408px;word-spacing:-0.9px;}
#t2b_2{left:471px;top:425px;word-spacing:4.6px;}
#t2c_2{left:471px;top:450px;word-spacing:5.1px;}
#t2d_2{left:471px;top:468px;word-spacing:5px;}
#t2e_2{left:471px;top:485px;word-spacing:10.3px;}
#t2f_2{left:471px;top:502px;word-spacing:17px;}
#t2g_2{left:471px;top:519px;word-spacing:8.7px;}
#t2h_2{left:471px;top:535px;word-spacing:3.5px;}
#t2i_2{left:471px;top:552px;word-spacing:5.1px;}
#t2j_2{left:471px;top:569px;word-spacing:4.6px;}
#t2k_2{left:490px;top:586px;word-spacing:3.6px;}
#t2l_2{left:471px;top:603px;word-spacing:4.7px;}
#t2m_2{left:471px;top:619px;word-spacing:6.2px;}
#t2n_2{left:471px;top:636px;word-spacing:7.7px;}
#t2o_2{left:471px;top:653px;word-spacing:5.1px;}
#t2p_2{left:471px;top:670px;word-spacing:1.6px;}
#t2q_2{left:471px;top:687px;word-spacing:4.6px;}
#t2r_2{left:802px;top:686px;}
#t2s_2{left:490px;top:704px;word-spacing:9px;}
#t2t_2{left:471px;top:720px;word-spacing:4.2px;}
#t2u_2{left:471px;top:737px;word-spacing:8.6px;}
#t2v_2{left:471px;top:754px;word-spacing:1.1px;}
#t2w_2{left:471px;top:771px;word-spacing:9.5px;}
#t2x_2{left:471px;top:788px;word-spacing:2.1px;}
#t2y_2{left:471px;top:804px;letter-spacing:0.5px;word-spacing:1.5px;}
#t2z_2{left:471px;top:821px;letter-spacing:0.9px;word-spacing:11.7px;}
#t30_2{left:471px;top:838px;letter-spacing:0.9px;word-spacing:4px;}
#t31_2{left:471px;top:855px;letter-spacing:0.9px;word-spacing:1.2px;}
#t32_2{left:471px;top:872px;letter-spacing:1.1px;}
#t33_2{left:471px;top:897px;word-spacing:5.1px;}
#t34_2{left:471px;top:915px;word-spacing:0.1px;}
#t35_2{left:471px;top:932px;word-spacing:-0.3px;}
#t36_2{left:471px;top:949px;word-spacing:0.9px;}
#t37_2{left:471px;top:966px;word-spacing:13.6px;}
#t38_2{left:471px;top:982px;word-spacing:10.4px;}
#t39_2{left:471px;top:999px;word-spacing:2.8px;}
#t3a_2{left:471px;top:1016px;word-spacing:-1px;}
#t3b_2{left:471px;top:1033px;word-spacing:5.7px;}
#t3c_2{left:471px;top:1050px;word-spacing:-1.2px;}
#t3d_2{left:471px;top:1066px;word-spacing:8.8px;}
#t3e_2{left:471px;top:1083px;word-spacing:10.2px;}
#t3f_2{left:471px;top:1100px;word-spacing:4.6px;}
#t3g_2{left:490px;top:1117px;word-spacing:4.8px;}
#t3h_2{left:471px;top:1134px;letter-spacing:0.8px;word-spacing:1.6px;}
#t3i_2{left:225px;top:37px;word-spacing:13.7px;}
#t3j_2{left:807px;top:37px;}

.s6_2{
	FONT-SIZE: 33.6px;
	FONT-FAMILY: KCFJPM-NewCenturySchlbk-Roman2;
	color: rgb(62,75,110);
}

.s3_2{
	FONT-SIZE: 67.2px;
	FONT-FAMILY: KCFJOF-Univers-Bold2;
	color: rgb(35,31,32);
}

.s8_2{
	FONT-SIZE: 55px;
	FONT-FAMILY: KCFJOF-Univers-Bold2;
	color: rgb(35,31,32);
}

.s7_2{
	FONT-SIZE: 55px;
	FONT-FAMILY: KCFLFD-Univers-Light2;
	color: rgb(35,31,32);
}

.s5_2{
	FONT-SIZE: 55px;
	FONT-FAMILY: KCFJPM-NewCenturySchlbk-Roman2;
	color: rgb(35,31,32);
}

.s1_2{
	FONT-SIZE: 61.1px;
	FONT-FAMILY: KCFJPM-NewCenturySchlbk-Roman2;
	color: rgb(35,31,32);
}

.s2_2{
	FONT-SIZE: 39.7px;
	FONT-FAMILY: KCFJPM-NewCenturySchlbk-Roman2;
	color: rgb(62,75,110);
}

.s4_2{
	FONT-SIZE: 61.1px;
	FONT-FAMILY: KCFJOF-Univers-Bold2;
	color: rgb(35,31,32);
}

.v2_2{
	-webkit-transform: scale(0.318, 0.25);
	-ms-transform: scale(0.318, 0.25);
	-moz-transform: scale(0.318, 0.25);
	-o-transform: scale(0.318, 0.25);
}

.v1_2{
	-webkit-transform: scale(0.288, 0.25);
	-ms-transform: scale(0.288, 0.25);
	-moz-transform: scale(0.288, 0.25);
	-o-transform: scale(0.288, 0.25);
}

#form2_1{	border-style:none;	z-index:2;	position: absolute;	left:801px;	top:686px;	width:15px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form2_2{	border-style:none;	z-index:2;	position: absolute;	left:232px;	top:141px;	width:19px;	height:14px;	text-align:left;	background: transparent;	font:normal 10px Arial, Helvetica, sans-serif;}
#form2_3{	border-style:none;	z-index:2;	position: absolute;	left:103px;	top:746px;	width:31px;	height:14px;	text-align:left;	background: transparent;	font:normal 10px Arial, Helvetica, sans-serif;}
#form2_4{	border-style:none;	z-index:2;	position: absolute;	left:107px;	top:287px;	width:32px;	height:14px;	text-align:left;	background: transparent;	font:normal 10px Arial, Helvetica, sans-serif;}
#form2_5{	border-style:none;	z-index:2;	position: absolute;	left:365px;	top:489px;	width:35px;	height:14px;	text-align:left;	background: transparent;	font:normal 10px Arial, Helvetica, sans-serif;}
#form2_6{	border-style:none;	z-index:2;	position: absolute;	left:125px;	top:397px;	width:37px;	height:14px;	text-align:left;	background: transparent;	font:normal 10px Arial, Helvetica, sans-serif;}

</style>
<style id="fonts2" type="text/css" >

@font-face {
	font-family: KCFJPM-NewCenturySchlbk-Roman2;
	src: url("2/fonts/KCFJPM-NewCenturySchlbk-Roman.woff") format("woff");
}

@font-face {
	font-family: KCFJOF-Univers-Bold2;
	src: url("2/fonts/KCFJOF-Univers-Bold.woff") format("woff");
}

@font-face {
	font-family: KCFLFD-Univers-Light2;
	src: url("2/fonts/KCFLFD-Univers-Light.woff") format("woff");
}

</style>
<div id="t1_2" class="t s1_2">to changes in penile blood ﬂow caused by plaque</div>
<div id="t2_2" class="t s1_2">formation or psychological due to patient concern</div>
<div id="t3_2" class="t s1_2">with the malformation.</div>
<div id="t4_2" class="t v1_2 s2_2">5,6</div>
<div id="t5_2" class="t s1_2">Historically various medical therapies have been</div>
<div id="t6_2" class="t s1_2">used to treat PD, including oral medication (vitamin</div>
<div id="t7_2" class="t s1_2">E, potassium aminobenzoate, tamoxifen, colchicine,</div>
<div id="t8_2" class="t s1_2">carnitine and pentoxifylline), injectable agents (col-</div>
<div id="t9_2" class="t s1_2">lagenase, interferon and verapamil), electromotive</div>
<div id="ta_2" class="t s1_2">therapy or iontophoresis and radiation therapy.</div>
<div id="tb_2" class="t s1_2">Limited clinical data show the efﬁcacy of these ther-</div>
<div id="tc_2" class="t s1_2">apies.</div>
<div id="td_2" class="t v1_2 s2_2">2,7–9</div>
<div id="te_2" class="t s1_2">Surgery is the standard of care for mod-</div>
<div id="tf_2" class="t s1_2">erate to severe cases of PD unresponsive to medical</div>
<div id="tg_2" class="t s1_2">therapy. However, surgery is only recommended for</div>
<div id="th_2" class="t s1_2">patients with sexual dysfunction in the stable phase</div>
<div id="ti_2" class="t s1_2">of disease since complications include penile short-</div>
<div id="tj_2" class="t s1_2">ening, sensory change, recurrent penile curvature</div>
<div id="tk_2" class="t s1_2">and ED.</div>
<div id="tl_2" class="t v1_2 s2_2">10–12</div>
<div id="tm_2" class="t s1_2">We present the results of a recent phase 2b study</div>
<div id="tn_2" class="t s1_2">to evaluate PD treatment with CCh (Xiaﬂex® or</div>
<div id="to_2" class="t s1_2">Xiapex®). CCh is a puriﬁed mix of 2 collagenases</div>
<div id="tp_2" class="t s1_2">(AUX-I and II) that showed safety and efﬁcacy in</div>
<div id="tq_2" class="t s1_2">patients with PD in early clinical studies.</div>
<div id="tr_2" class="t v1_2 s2_2">13–16</div>
<div id="ts_2" class="t s1_2">This</div>
<div id="tt_2" class="t s1_2">early clinical program consisted of 5 studies of 299</div>
<div id="tu_2" class="t s1_2">subjects with PD over a wide dose range with</div>
<div id="tv_2" class="t s1_2">slightly different study end points, evaluation meth-</div>
<div id="tw_2" class="t s1_2">ods and study procedures that investigators used to</div>
<div id="tx_2" class="t s1_2">build to the design of the current phase 2b study.</div>
<div id="ty_2" class="t s1_2">CCh at a dose of 0.58 mg (10,000 U) per injection is</div>
<div id="tz_2" class="t s1_2">approved by the United States Food and Drug Admin-</div>
<div id="t10_2" class="t s1_2">istration, and the European Medicines Agency for Du-</div>
<div id="t11_2" class="t s1_2">puytren contracture, a collagen disorder of the hand.</div>
<div id="t12_2" class="t s1_2">To facilitate enzymatic cord disruption in these cases</div>
<div id="t13_2" class="t s1_2">CCh is injected directly into a palpable cord, followed</div>
<div id="t14_2" class="t s1_2">by a ﬁnger extension procedure intended to further</div>
<div id="t15_2" class="t s1_2">disrupt the cord that was weakened by the collage-</div>
<div id="t16_2" class="t s1_2">nase.</div>
<div id="t17_2" class="t v1_2 s2_2">17,18</div>
<div id="t18_2" class="t s1_2">In the current phase 2b study we examined</div>
<div id="t19_2" class="t s1_2">the ability of CCh treatment to improve penile curva-</div>
<div id="t1a_2" class="t s1_2">ture as well as its effect on a PD speciﬁc PD-PRO. We</div>
<div id="t1b_2" class="t s1_2">also assessed the safety of penile injections of CCh.</div>
<div id="t1c_2" class="t s3_2">MATERIALS AND METHODS</div>
<div id="t1d_2" class="t s4_2">Study Design</div>
<div id="t1e_2" class="t s5_2">A phase 2b, randomized, double-blind, placebo controlled</div>
<div id="t1f_2" class="t s5_2">study of CCh was done in subjects with PD from 12 Amer-</div>
<div id="t1g_2" class="t s5_2">ican sites. Institutional review board approval was ob-</div>
<div id="t1h_2" class="t s5_2">tained from all sites (central quorum and/or institutional).</div>
<div id="t1i_2" class="t s5_2">Appendix 1 lists study inclusion and exclusion criteria. Ef-</div>
<div id="t1j_2" class="t s5_2">ﬁcacy and safety assessments for all subjects were recorded</div>
<div id="t1k_2" class="t s5_2">during 36 weeks. All subjects were recruited by the investi-</div>
<div id="t1l_2" class="t s5_2">gators and received a nominal fee to participate in the study.</div>
<div id="t1m_2" class="t s4_2">Treatment</div>
<div id="t1n_2" class="t s5_2">Subjects were stratiﬁed by degree of penile curvature (30</div>
<div id="t1o_2" class="t s5_2">to 60 or greater than 60 degrees) and randomized into 4</div>
<div id="t1p_2" class="t s5_2">groups using the Interactive Web Response Services ran-</div>
<div id="t1q_2" class="t s5_2">domization computer system, including CCh or placebo</div>
<div id="t1r_2" class="t s5_2">(3:1) with or without penile plaque modeling (1:1). All</div>
<div id="t1s_2" class="t s5_2">investigators were assigned in blinded fashion to active vs</div>
<div id="t1t_2" class="t s5_2">placebo treatment using the Interactive Web Response</div>
<div id="t1u_2" class="t s5_2">Services program and given drug kits that were visually</div>
<div id="t1v_2" class="t s5_2">identical.</div>
<div id="t1w_2" class="t s5_2">Each cycle consisted of 2 injections of CCh (0.58 mg or</div>
<div id="t1x_2" class="t s5_2">10,000 U) or placebo with an interval of 24 to 72 hours</div>
<div id="t1y_2" class="t s5_2">between the injections. This regimen was repeated after 6</div>
<div id="t1z_2" class="t s5_2">weeks for up to 3 treatment cycles. A 26 or 27 gauge needle</div>
<div id="t20_2" class="t s5_2">was used to inject CCh or placebo directly into the primary</div>
<div id="t21_2" class="t s5_2">plaque at the point of maximal curvature. After the needle</div>
<div id="t22_2" class="t s5_2">was positioned properly in the plaque the study medica-</div>
<div id="t23_2" class="t s5_2">tion was injected as the needle was withdrawn to deposit</div>
<div id="t24_2" class="t s5_2">the drug along the needle track.</div>
<div id="t25_2" class="t s5_2">Between 24 and 72 hours after the second injection of</div>
<div id="t26_2" class="t s5_2">each treatment cycle, subjects randomized to modeling</div>
<div id="t27_2" class="t s5_2">underwent gradual, gentle stretching of the ﬂaccid penis</div>
<div id="t28_2" class="t s5_2">in the opposite direction of the curvature. The physician</div>
<div id="t29_2" class="t s5_2">held the stretched position for 30 seconds, before allowing</div>
<div id="t2a_2" class="t s5_2">the penis to return to the nonmodeled state for 30 seconds.</div>
<div id="t2b_2" class="t s5_2">This procedure was repeated 3 times.</div>
<div id="t2c_2" class="t s4_2">Efﬁcacy and Safety Assessments</div>
<div id="t2d_2" class="t s5_2">Penile length and plaque measurements were made on a</div>
<div id="t2e_2" class="t s5_2">stretched, ﬂaccid penis using a cm ruler or calipers. To</div>
<div id="t2f_2" class="t s5_2">accurately measure penile curvature subjects were in-</div>
<div id="t2g_2" class="t s5_2">jected with prostaglandin E1 to induce erection and the</div>
<div id="t2h_2" class="t s5_2">angle was determined using a goniometer protractor. Ad-</div>
<div id="t2i_2" class="t s5_2">ditional PD speciﬁc symptoms were assessed by the phy-</div>
<div id="t2j_2" class="t s5_2">sician and documented as mild, moderate or severe.</div>
<div id="t2k_2" class="t s5_2">The PD-PRO and IIEF were used to assess the impact</div>
<div id="t2l_2" class="t s5_2">of PD on patient quality of life and erectile function. PD-</div>
<div id="t2m_2" class="t s5_2">PRO questions were grouped into domains, including in-</div>
<div id="t2n_2" class="t s5_2">tercourse discomfort and constraint, penile pain and PD</div>
<div id="t2o_2" class="t s5_2">symptom bother. For the IIEF questionnaire patients re-</div>
<div id="t2p_2" class="t s5_2">ported the domains of erectile and orgasmic function, sex-</div>
<div id="t2q_2" class="t s5_2">ual desire, and intercourse and overall satisfaction.</div>
<div id="t2r_2" class="t v2_2 s6_2">19</div>
<div id="t2s_2" class="t s5_2">Primary efﬁcacy end points were the change and the</div>
<div id="t2t_2" class="t s5_2">percent change from baseline to week 36 in penile curva-</div>
<div id="t2u_2" class="t s5_2">ture and the change in total score for each PD-PRO do-</div>
<div id="t2v_2" class="t s5_2">main. Safety analysis was based on the AE incidence, and</div>
<div id="t2w_2" class="t s5_2">the change from baseline in laboratory values and vital</div>
<div id="t2x_2" class="t s5_2">signs. AEs were considered treatment emergent when ob-</div>
<div id="t2y_2" class="t s5_2">served at any time after the ﬁrst dose of CCh. They were</div>
<div id="t2z_2" class="t s5_2">considered treatment related when deﬁned by the in-</div>
<div id="t30_2" class="t s5_2">vestigator as possibly or probably related to CCh treat-</div>
<div id="t31_2" class="t s5_2">ment. Immunogenicity was assessed with CCh antibody</div>
<div id="t32_2" class="t s5_2">titers.</div>
<div id="t33_2" class="t s4_2">Statistical Analysis</div>
<div id="t34_2" class="t s5_2">Power calculations were based on the percent reduction in</div>
<div id="t35_2" class="t s5_2">penile curvature and on the degree of interaction assumed</div>
<div id="t36_2" class="t s5_2">between the drug effect and the modeling effect. A sample</div>
<div id="t37_2" class="t s5_2">size of 120 subjects was determined to be sufﬁcient to</div>
<div id="t38_2" class="t s5_2">measure the effect of the drug (CCh vs placebo) with a</div>
<div id="t39_2" class="t s5_2">power of at least 90%. The ITT population was deﬁned as</div>
<div id="t3a_2" class="t s5_2">all randomized subjects who received at least 1 injection of</div>
<div id="t3b_2" class="t s5_2">study drug. The mITT population was deﬁned as all ITT</div>
<div id="t3c_2" class="t s5_2">subjects in whom at least 1 penile curvature measurement</div>
<div id="t3d_2" class="t s5_2">was made after the ﬁrst injection of study drug. Only 2</div>
<div id="t3e_2" class="t s5_2">patients were excluded from the CCh without modeling</div>
<div id="t3f_2" class="t s5_2">group according to these criteria.</div>
<div id="t3g_2" class="t s5_2">The PD-PRO population was deﬁned as all mITT sub-</div>
<div id="t3h_2" class="t s5_2">jects who completed a PD-PRO response at baseline and</div>
<div id="t3i_2" class="t s7_2">PHASE 2B STUDY OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM</div>
<div id="t3j_2" class="t s8_2">2269</div>

<form>
<input type="button"  tabindex="6"  id="form2_1" name="130 0 R"  pdfFieldName="130 0 R" onclick="window.location.href='7.html';" style="cursor:pointer;"  title="Page 7" />
<input type="button"  tabindex="1"  id="form2_2" name="125 0 R"  pdfFieldName="125 0 R" onclick="window.location.href='7.html';" style="cursor:pointer;"  title="Page 7" />
<input type="button"  tabindex="5"  id="form2_3" name="129 0 R"  pdfFieldName="129 0 R" onclick="window.location.href='7.html';" style="cursor:pointer;"  title="Page 7" />
<input type="button"  tabindex="2"  id="form2_4" name="126 0 R"  pdfFieldName="126 0 R" onclick="window.location.href='7.html';" style="cursor:pointer;"  title="Page 7" />
<input type="button"  tabindex="4"  id="form2_5" name="128 0 R"  pdfFieldName="128 0 R" onclick="window.location.href='7.html';" style="cursor:pointer;"  title="Page 7" />
<input type="button"  tabindex="3"  id="form2_6" name="127 0 R"  pdfFieldName="127 0 R" onclick="window.location.href='7.html';" style="cursor:pointer;"  title="Page 7" />

</form>
<div id="pg2Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg2"><object width="893" height="1196" data="2/2.svg" type="image/svg+xml" id="pdf2" style="width:893px; height:1196px; background-color:white; -moz-transform:scale(1); z-index: 0;"></object></div>
<!--[if lt IE 9]><script type="text/javascript">
var divCount = 128;
for (var i = 1; i < divCount; i++) {
    var div = document.getElementById("t" + i.toString(36) + "_2");
    if (div !== null) {
        div.style.top = (div.offsetTop * 4) + "px";
        div.style.left = (div.offsetLeft * 4) + "px";
        div.style.zoom = "25%";
    }
}
</script><![endif]-->

</div>
